Drug
Who makes lisdexamfetamine dimesylate?
16 companies list lisdexamfetamine dimesylate as a human prescription drug, including under the names Vyvanse. Forms: capsule; tablet, chewable. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing lisdexamfetamine dimesylate
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LimitedIndia | capsule; tablet, chewable | ANDAANDA214134, ANDA214484 | 13 | 13 |
| Granules Pharmaceuticals Inc.India | capsule; tablet, chewable | ANDAANDA218987, ANDA219258 | 13 | 8 |
| Takeda Pharmaceuticals U.S.A., Inc.Germany | capsule; tablet, chewable | NDANDA021977, NDA208510 | 13 | 7 |
| Teva Pharmaceutical Industries Ltd.Canada | capsule; tablet, chewable | ANDAANDA202802, ANDA215415 | 13 | 6 |
| SpecGx LLCUnited States | capsule; tablet, chewable | ANDAANDA211840, ANDA218850 | 13 | 5 |
| Camber Pharmaceuticals, Inc.United States | capsule; tablet, chewable | ANDAANDA217068, ANDA217442 | 13 | 1 |
| Bryant Ranch PrepackUnited States | capsule | ANDAANDA214547, ANDA215330 | 8 | 1 |
| Apotex Inc.Canada | capsule | ANDAANDA216944 | 7 | 6 |
| Sandoz Industrial Products S.AAustria | capsule | ANDAANDA202836 | 7 | 5 |
| Hikma Pharmaceuticals USA Inc.United States | capsule | ANDAANDA202827 | 7 | 4 |
| Elite Laboratories, Inc.United States | capsule | ANDAANDA218604 | 7 | 1 |
| Lannett Company, LLCUnited States | capsule | ANDAANDA215802 | 7 | 1 |
| Alvogen, Inc. | capsule | ANDAANDA214547 | 7 | 0 |
| Rhodes Pharmaceuticals LLC | capsule | ANDAANDA215330 | 7 | 0 |
| Pharma Packaging Solutions, LLC dba Tjoapack, LLCUnited States | capsule | ANDAANDA217442 | 6 | 5 |
| Novadoz Pharmaceuticals LLC | tablet, chewable | ANDAANDA218306 | 6 | 0 |
Bulk ingredient listings
- Cambrex Charles City, Inc. · 4 NDC
- Chattem Chemicals, Inc.United States · 1 NDC
- Curia New York, Inc. · 1 NDC
- Euticals, Inc. · 1 NDC
- Noramco, LLCUnited States · 1 NDC
- S&B Pharma LLC dba Norac PharmaUnited States · 1 NDC
- SpecGx LLCUnited States · 1 NDC
- Veranova, L.P.United States · 1 NDC
- Viyash Scientific LimitedIndia · 1 NDC
Orange Book patents
3 unexpired patents list lisdexamfetamine dimesylate as the active ingredient, expiring between Apr 2040 and Aug 2040. Application holder: AZURITY PHARMACEUTICALS INC.
Enquiry
Common questions
- Who makes lisdexamfetamine dimesylate?
- 16 companies list lisdexamfetamine dimesylate as a human prescription drug in the openFDA NDC Directory, led by Sun Pharmaceutical Industries Limited, Granules Pharmaceuticals Inc., Takeda Pharmaceuticals U.S.A., Inc., Teva Pharmaceutical Industries Ltd., SpecGx LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Vyvanse?
- 15 companies list lisdexamfetamine dimesylate under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies lisdexamfetamine dimesylate active ingredient?
- 9 companies list lisdexamfetamine dimesylate as a bulk ingredient, including Cambrex Charles City, Inc., Chattem Chemicals, Inc., Curia New York, Inc., Euticals, Inc..